Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Vertice Pharma Appoints R&D VP | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

Vertice Pharma Appoints R&D VP

Dr. Nandi brings 15 years of drug development expertise

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. Indranil Nandi has been appointed vice president, R&D at Vertice Pharma. Most recently, Dr. Nandi served as vice president, Generic R&D for Impax Laboratories. Dr. Nandi also held positions of increasing responsibilities at Sandoz, including executive director, Portfolio, Project Management and Scientific Affairs. He also worked in various positions in R&D at Par Pharmaceuticals and Geneva Pharmaceuticals.
 
“We are delighted to welcome Dr. Nandi to the Vertice Pharma leadership team. Dr. Nandi brings over 15 years of extensive multi-disciplinary expertise in drug development and portfolio management across a broad range of therapeutic areas and dosage forms. Dr. Nandi has a proven track record in drug development and I have every confidence in his ability to lead Vertice’s Research & Development efforts. His extensive network and his experience in progressing collaborative projects will be key to building an even more robust product pipeline and driving our growth strategy,” said Don DeGolyer, President & Chief Executive Officer of Vertice Pharma.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics